-
Symbol
-
MAZE on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001
-
Latest Disclosed Ownership
-
609K shares
-
Security Ownership
-
1.4%
James Tananbaum ownership in Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE)
2025-11-14 - James Tananbaum has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 609K shares of Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE).
This represents 1.4% percent ownership of the company.
In their previous filing dated 2025-02-07, Foresite Capital Fund IV, L.P. had reported owning 2.46M shares, indicating a decrease of -75.2% percent.